NEUP Neuphoria Therapeutics, Inc.: Net Asset Value
The prospects for Neuphoria Therapeutics Inc. (NEUP) rely on the efficacy of BNC210 in treating anxiety disorders and the search for a partner to bring the product to market. Quotes depend on final tests, ignoring general market cycles, and the indicator stands at 0.02. The price trend illustrated in this chart visualizes the dynamics of this biotech project, where the accuracy of research data is ensured by a strict temperature regime for drug transportation.
NEUP (Neuphoria): analytical breakdowns and indicator data
- current quotes and average value forecast:
- company stock capitalization data:
- book capitalization information:
- debt and liquidity data:
Total Debt to Capital Neuphoria Therapeutics Inc.|NEUP - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Neuphoria Therapeutics Inc.|NEUP - Company Debts|Debts to Book Value Neuphoria Therapeutics, Inc.|NEUP - Company Long-Term Debt|Company Short-Term Indebtedness Neuphoria Therapeutics|Immediate Liquidity bionomics.com.au
- earnings and valuation multiples information:
Initial company analysis:NEUP, Neuphoria Therapeutics
The virtual model of Neuphoria Therapeutics Inc. (NEUP), featuring full outsourcing of synthesis and testing, leaves the company dependent on external financing and patent management. The dynamics of the book capitalization value reflect the daily balance of net assets minus liabilities, allowing investors to track the burn rate and assess bankruptcy risk or the need for a secondary offering through the analysis of this chart.
Competitor analysis
BIIB - Book Capitalization|Neurocrine Biosciences (NBIX) - Company Book Value|Net Asset Value RGC (regencellbioscience.com)|Company Book Value Axsome Therapeutics, Inc.|Accounting Capitalization ACAD (ACADIA Pharma)|Book Capitalization XENE|VKTX - Total Stockholders' Equity|Supernus Pharmaceuticals - Company Net Assets|Book Capitalization catalystpharma.com CPRX|DNLI - Company Book Value|Accounting Value of Company HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Company Book Value|Total Stockholders' Equity Amylyx Corp (AMLX)|Company Book Value Trevi Therapeutics|Accounting Capitalization PRAX (praxismedicines.com)|Book Capitalization AVXL|CBLL - Total Stockholders' Equity|prothena.com - Company Net Assets|Book Capitalization Alector Inc. ALEC|ANNX - Company Book Value|Net Asset Value OMER|NGNE: Book Capitalization|AC Immune S.A. - Accounting Value of Company|Company Book Value Voyager Pharma|Total Stockholders' Equity Neumora Corp NMRA|Company Book Value Scilex Holding Company (SCLX)|TVGN (tevogen.com) - Accounting Value of Company|Book Capitalization ACOG (Alpha Cognition Inc.)|Book Valuation of Business cogrx.com (CGTX)|Inhibikase - Book Capitalization|SAVA - Book Capitalization|ASRT (assertiotx.com) - Company Net Assets|Coya Therapeutics - Accounting Value of Company|Company Net Assets VTGN|OVID (Ovid Rx) - Total Net Assets|Book Capitalization ABOS|CRVO (CervoMed Corporation) - Accounting Value of Company|Book Capitalization ATHE (Alterity Therapeutics Limited)|Clene Inc (CLNN) - Total Stockholders' Equity|PEPG - Company Book Value|Accounting Value of Company JUNS (jupiterneurosciences.com)|RLMD: Book Capitalization|Annovis Bio Corporation (ANVS) - Book Capitalization|Company Book Value Grace Therapeutics Inc|fireflyneuro.com - Net Asset Value|Book Capitalization KLTO|NRSN - Total Stockholders' Equity|Reviva Pharmaceuticals Holdings - Company Net Assets|Book Capitalization MetaVia Inc. MTVA|NRXS: Company Net Assets|Helius Medical - Total Net Assets|PASG: Book Capitalization|NERV - Book Valuation of Business|ATHA (Athira) - Book Capitalization|Company Net Assets Addex (ADXN)|Company Book Value Alzamend Neuro, Inc. (ALZN)|Book Valuation of Business cyclerion.com|Protagenic Therapeutics, Inc. - Company Net Assets|Accounting Value of Company KTTA|Cortigent Medical - Book Capitalization|Book Valuation of Business Avenue Therapeutics Inc ATXI|Brainstorm Cell (BCLI) - Company Book Value|Accounting Capitalization CARA|CHRO (Chromocell Therapeutics Corp.) - Book Capitalization|Company Net Assets Eliem (ELYM)|Company Net Assets ITCI (Intra-Cellular Therapies)|Book Valuation of Business Longboard|Company Book Value Marinus Pharmaceuticals MRNS|NKGN: Accounting Capitalization|NeuroBo Pharmaceuticals, Inc. - Book Capitalization|Total Stockholders' Equity Sage Therapeutics Inc.|SNPX (Neurotrope) - Company Net Assets|Trevena Inc (TRVN) - Book Capitalization|Company Book Value Vigil Neuroscience Inc.|Anew Medical Inc. - Net Asset Value|Company Book Value Cerevel Therapeutics, Inc. (CERE)